BUY Glenmark Pharmaceuticals — Prashant P. Sawant, 13 Aug 2026

BUYGlenmark Pharmaceuticals

Glenmark Pharmaceuticals share price target & all analyst calls

byPrashant P. SawantHorizon: NA (inferred Intraday)13 Aug 2026, 1:05 pm ISTvia CNBC Awaaz.

Entry₹2,302.7Inferred

Target₹2,350

Total upside +2.05%

Stop loss₹2,275-1.20% risk

At expiry₹2,318.513 Aug 2026, 3:05 pm

Expired+0.69%

Follow Prashant P. Sawant for new calls(5% target hit, 19 closed calls)Get alerts Watch GLENMARK for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Aug 2026

1 supporting1 neutral2 opposing

Supports the BUY call (1)

3 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·12 Aug · yesterday

Neutral / worth noting (1)

Glenmark USA has agreed to a settlement of $15.28 million to resolve antitrust and consumer protection lawsuits related to price-fixing allegations. The company denies all allegations and states the s

BSE · Company Update·11 Aug · yesterday

Weighs against the BUY call (2)

Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

NewsCnbc-Tv18·12 Aug · yesterday

1 advisor has an active swing SELL call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·7 Aug · 6d ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Prashant P. Sawant

Every call and its outcome